(Press-News.org) Vancouver, British Columbia – External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been standardized, as it has been limited to software that requires oncologists to manually define the areas of tumors. A new "phantom" model of the human form that can be deformed and reformed to match anatomy in a matter of hours using 3D graphic design software is being combined with a precision method for predicting how radionuclide therapies interact with tissues to determine the most effective cancer-killing dose for every patient.
"One-size-fits all therapy is not optimal for patients who could be getting personalized cancer treatment," said Susan Kost, MS, principal author of the study from Vanderbilt University in Nashville, Tenn. "With individualized patient modeling we have an opportunity to offer more aggressive radionuclide therapy. Knowing a patient's drug kinetics and anatomy means we can give the maximum dose possible while minimizing effects on normal tissue."
The geometric design technology used for these anthropomorphic models, created by Paul Segars, PhD, at Duke University, is called NURBS (non-uniform rational b-splines). With NURBS, anatomical volumes derived from computed tomography imaging data of patients' organs and body parts are sculpted, rotated and scaled to create a model within one to two hours. Once a model is made, it is used for treatment planning in conjunction with single photon emission computed tomography or positron emission tomography, which—in most cases—use non-therapeutic imaging agents to mimic therapeutic radioactivity in the body. This allows physicians to extrapolate a precise dose, a process called dosimetry, via a 3D map representing projected dose absorption.
Ordinarily, dosimetry is performed by defining the structure and volume of tumors manually in 3D computer programs, known as tumor segmentation. However, this method can be labor intensive and may not provide dose information for normal tissue. In this study, patient-specific NURBS models serve as input in automated dosimetry calculations to factor anatomical data and radiopharmaceutical kinetics for I-131 radioimmunotherapy, specifically looking at the distribution of radioactive particles in the body as they seek out physiological processes of cancer cells and tissues. In action, tumor-tailored monoclonal antibodies are labeled with a potent dose of a radioisotope, and together they bind to receptors on the surface of cancer cells, effectively killing them and sparing nearby healthy cells.
"This research brings nuclear medicine therapy alongside external beam radiation therapy," Kost added. "Now each patient can receive his or her own therapy plan, leading to improved outcomes, better survival rates and less toxicity and harm to normal tissue in the body."
The NURBS phantom models are currently available for clinical use, and Kost expects the modeling toolkit to be used in a subsequent clinical trial conducted by Vanderbilt University for a tumor-targeted peptide receptor radionuclide therapy. A commercially viable version of the dosimetry software is scheduled for release to other cancer centers starting sometime next year.
###
Scientific Paper 49: Susan Kost and Michael Stabin, Vanderbilt University, Nashville, TN; and William Segars, Radiology, Duke University, Durham, NC, "Patient-specific dosimetry based on deformable anthropomorphic models," SNMMI's 60th Annual Meeting, June 8, 2013, Vancouver, British Columbia.
Software toolkit shapes models for personalized radionuclide therapy
Radionuclide drug treatment planning goes to the next level with 3-D patient models and quantification of therapeutic dose
2013-06-11
ELSE PRESS RELEASES FROM THIS DATE:
Pre-Alzheimer's: Metabolic disorder found in cognitively normal patients
2013-06-11
Vancouver, British Columbia – Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease—even for people with no sign of cognitive decline. This is a new development in the understanding of Alzheimer's pathology, say neuroscientists unveiling the research at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
"This study shows that ...
Molecular imaging finds hurdle for smokers' vaccine
2013-06-11
Vancouver, British Columbia – Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain. One of the newest studies of a proposed vaccine shows mixed results for patients after molecular imaging revealed no desirable effect and potentially allowed even more nicotine accumulation in the brain in some cases due to variations in immune response, say neuroscientists at the Society of Nuclear ...
High sugar intake linked to low dopamine release in insulin resistant patients
2013-06-11
Vancouver, British Columbia – Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes. For those who have the metabolic syndrome, a sugar drink resulted in a lower-than-normal release of the chemical dopamine in a major pleasure center of the brain. This chemical response may be indicative of a deficient reward system, which could potentially be setting the stage for insulin resistance. This ...
Radiopeptide therapy improves survival outcomes for neuroendocrine cancer patients
2013-06-11
Vancouver, British Columbia – Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide study in Germany deemed PRRT treatment not only safe and effective but life-prolonging, according to a study unveiled during the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
PRRT is a new and yet-to-be-approved treatment for patients with neuroendocrine tumors (NETs). These develop when ...
Molecular imaging enlists prostate enzyme to detect metastases
2013-06-11
Vancouver, British Columbia – No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer detection, staging, treatment and post-treatment monitoring, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
"There are currently no ideal imaging techniques in clinical practice that are specific to prostate cancer," said ...
Radioimmunotherapy could extend lives of advanced lymphoma patients
2013-06-11
Vancouver, British Columbia – A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. In a study presented at the meeting, survival rates without recurrence improved with the addition of RIT, with some having a 100 percent chance of survival ...
Breast cancer: PET and MR predict chemotherapy's ability to prolong life
2013-06-11
Vancouver, British Columbia – For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
Researchers combined separate imaging systems—PET, MR and CT—to map the course of chemotherapy before surgery, otherwise known as neoadjuvant chemotherapy. These different imaging systems ...
PET/MR effective for imaging recurrent prostate cancer
2013-06-11
Vancouver, British Columbia – When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment. A relatively new imaging system that simultaneously combines positron emission tomography and magnetic resonance (PET/MR) demonstrates a higher capacity for mapping recurrent prostate cancer than the already high standard of integrated PET and computed tomography (PET/CT), say researchers presenting ...
Hormonal treatment for endometrial cancer does not directly target the malignant cells
2013-06-11
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Like tumors of the breast and prostate, endometrial cancer is regulated by hormones. Unlike therapies for breast and prostate cancer, where drugs are given to block hormone signaling, in therapy for endometrial cancer progesterone is given to stimulate its hormone receptor. ...
Plunging fish numbers linked to dam releases
2013-06-11
A significant decline in the numbers of native fish in Australia's Murray-Darling Basin may be linked to released dam water being too cold for breeding.
This is just one of the findings from a Griffith University led study which found current water releases back into the Murray-Darling system limit fish reproduction and therefore impact freshwater biodiversity.
Griffith University Research Fellow Dr Rob Rolls said the results, published in Freshwater Biology, throw cold water on the notion that large dam releases compensate for the effects of interrupting natural water ...
LAST 30 PRESS RELEASES:
JMIR Publications’ Journal of Medical Internet Research invites submissions on Digital Health Strategic Planning
New cancer drug shows exceptional tumor-fighting potential
Spectral shaper provides unprecedented control over 10,000 laser frequency comb lines
Global Virus Network welcomes new centers of excellence across the Americas
Africa acacias ‘go for broke’ to grow, use up water to survive drought
An app, an Apple Watch and AI: UMass Amherst creates a new way for researchers to study sleep health
Sharing positive emotions with a partner is good for health
Ergonomic insect headgear and abdominal buckle with surface stimulators manufactured via multimaterial 3D printing snap-and-secure installation of noninvasive sensory stimulators for cyborg insects
Pharmacological insights into Scleromitrion diffusum (Willd.) against gastric cancer: active components and mechanistic pathways
Advanced imaging strategies based on intelligent micro/nanomotors
How climate-damaging nitrous oxide forms in the ocean
N6-methyladenosine methylation emerges as a key target for treating acute lung injury
Distributor-type membrane reactor for carbon dioxide methanation
Mapping the missing green: An AI framework boosts urban greening in Tokyo
Pharmacists help cancer patients manage high blood sugar more effectively
Babies’ gut bacteria may influence future emotional health
Scientists create new type of semiconductor that holds superconducting promise
Genes associated with obesity shared across ancestries, researchers find
Antidepressants improve core depressive symptoms early on
Superconducting germanium made with industry-compatible methods
Synthetic biology to supercharge photosynthesis in crops
Soil ‘memory’ can help plants respond to drought
Illinois researchers convert food waste into jet fuel, boosting circular economy
Under embargo: We learn physical skills by feeling rewarded, even in the absence of a reward, finds new study
Scientists on ‘urgent’ quest to explain consciousness as AI gathers pace
Drones reveal unexpectedly high emissions from wastewater treatment plants
Dancing alleviated perceived symptoms of depression and helped to understand its root causes
Tricky treats: Why pumpkins accumulate pollutants
Revealing the molecular structures of sugars using galectin-10 protein crystals
World’s leading medical journal details the climate emergency
[Press-News.org] Software toolkit shapes models for personalized radionuclide therapyRadionuclide drug treatment planning goes to the next level with 3-D patient models and quantification of therapeutic dose